Dr. Gordon A. Brown, DO

Dr. Brown practices at Reconstructive Orthopedics, PA in Sewell, New Jersey.

Dr. Brown's NPI, 1124192489, was assigned on November 20, 2006. Dr. Brown graduated from Rutgers New Jersey Medical School in 1998. Dr. Brown holds New Jersey license 25MB06991400.

Dr. Brown's primary practice is Reconstructive Orthopedics, PA, at 570 Egg Harbor Rd, Sewell, NJ 08080 in Gloucester County. The practice phone is (609) 267-9400.

Dr. Brown's primary practice is Reconstructive Orthopedics, PA in Sewell, New Jersey. Dr. Brown is also affiliated with Cooper University Hospital. The medical group on file is Summit Health. Dmand AI also links Dr. Brown to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brown practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Brown's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Brown's licenses on file in 2 states: New Jersey and Texas.

CMS data shows 11,769 Medicare services from Dr. Brown across 41 procedure codes in 2024, for 1,439 Medicare patients. Medicare paid $487,434 for them.

CMS counts 1,439 Medicare patients who saw Dr. Brown in 2024. The largest group is 65 to 74, with 649 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brown's median patient age at 72, with 15% women.

In 2024, Dr. Brown wrote 5,449 Medicare Part D claims for 1,201 patients. 80% of them were for generic drugs. CMS names the drug for 5,234 of them, across 42 drugs with 11 or more claims each, at $7,740,403 in total drug cost. In 2023, CMS named 4,217 claims across 35 drugs.

Dr. Brown accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 80 papers to Dr. Brown, published from 2011 to 2025. 2015 was the busiest year, with 9. The most frequent topics are Models, Psychological, Mental Recall and Prostatic Neoplasms. Dr. Brown has published most often in Rev Urol. Dr. Brown's most frequent co-authors are Benjamin Hugh Lowentritt, MD, Michael Joseph Donovan, MD, PhD and Stacy L. Loeb, MD.

Dmand AI links Dr. Brown to 4 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell and Prostatic Neoplasms. UroGen Pharma Ltd. sponsors the most, 2. Open Payments lists research payments to Dr. Brown that name 1 trial.

CMS Open Payments shows 1,683 general payments to Dr. Brown from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Janssen Pharmaceuticals, Inc paid the most, $523,834. It also lists 3 research payments totaling $10,815 from 2016 to 2021, naming 1 clinical trial.

Dr. Brown graduated from Rutgers New Jersey Medical School in 1998.